Media Releases

Jul 29 -	Immunovaccine Appoints Albert Scardino as New Board Member
Jul 12 -	Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA
Jun 29 -	Immunovaccine Signs Agreement with Oncothyreon to Develop Cancer Vaccine
Jun 11 -	Warwick Kimmins Science Scholarship Awarded
Jun 9 -	Immunovaccine Appoints Acting CFO
Jun 7 -	Immunovaccine Announces the Departure of its Chief Financial Officer
Jun 7 -	Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine
May 17 -	Immunovaccine Appoints Paul Kirkconnell to Board, Announces Retirement of Denis Ryan
May 12 -	Immunovaccine Announces 2010 First Quarter Results
Apr 22 -	Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute
Apr 19 -	Immunovaccine Announces 2009 Year End Results
Apr 5 -	Immunovaccine Announces the Publication of DPX-0907 Preclinical Study
Mar 29 -	Immunovaccine Begins Patient Recruitment for Phase I Trial of DPX-0907 Cancer Vaccine
Mar 2 -	Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine
Feb 23 -	Immunovaccine Appoints James Hall as New Board Member
Feb 8 -	Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
Feb 4 -	Immunovaccine Provides Corporate Update
Feb 2 -	Immunovaccine Hires Investor Relations Firm
Jan 28 -	Immunovaccine Grants Stock Options